Ivan Ilić
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ivan Ilić has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Pavle J. Randjelovic
Department of Physiology, Faculty of Medicine, University of Nis, 18000 Nis, Serbia
10 shared publications - Maja Jovicic-Milentijevic
Center for Pathology and Pathological Anatomy, University Clinical Center Niš, Faculty of Medicine, University of Niš, 18000 Niš, Serbia
4 shared publications - Nikola M. Stojanovic
Centre for Mental Health Protection, University Clinical Centre Niš, 18000 Niš, Serbia
4 shared publications - Ilija Golubovic
Medical Faculty, University of Nis, Clinic for Digestive Surgery, University Clinical Center Nis, 18000 Nis, Serbia
3 shared publications - Niko S. Radulović
Department of Chemistry, Faculty of Sciences and Mathematics, University of Niš, Višegradska 33, 18000 Niš, Serbia
3 shared publications - Biljana Radovanović Dinić
Clinic for Gastroenterology and Hepatology, University Clinical Center Niš, Faculty of Medicine, University of Niš, 18000 Niš, Serbia
2 shared publications
Latest Publications
- Open Access
Clinical Significance of High-Risk HPV Positivity with Negative Cytology: Can Further Evaluation Be Safely Delayed?
Background and Objectives: Primary HPV screening has high sensitivity in detecting premalignant and malignant cervical lesions. However, due to its relatively low specificity, this screening approach requires triage tests. Owing to its high specificity, cytology is most commonly employed in the triage of HPV-positive results. Nevertheless, the question remains as to how reliable cytology is in triaging these cases, given its relatively low sensitivity. This study evaluates the clinical significance of high-risk HPV (hrHPV) positivity in women with negative or low-grade cytological findings and assesses whether further evaluation can be safely deferred using HPV genotyping, colposcopy, and p16/Ki-67 biomarkers. Materials and Methods: A prospective hospital-based observational study was conducted on 125 women with a positive hrHPV cervical test. All participants underwent conventional cytology, extended HPV genotyping, colposcopy, and histopathological evaluation via biopsy or loop excision. Immunohistochemical analysis of p16 and Ki-67 expressions was performed on histopathological tissue samples. Particular attention was focused on women with negative for intraepithelial lesion or malignancy (NILM) and low-grade cytological findings. Associations between cytology, HPV genotype distribution, colposcopic findings, histopathology, smoking status, and biomarker expression were analyzed. Results: Among HPV-positive patients with NILM cytology, CIN2+ lesions were histopathologically confirmed in 28.0% of cases. More than half (51.4%) of all CIN2+ lesions detected in HPV-positive women were identified in patients with low-grade or negative cytology. HPV16/18 positivity was highly prevalent among women with CIN2+ lesions and low-grade cytological findings (78.4%). Unsatisfactory colposcopy with a non-visible squamocolumnar junction (transformation zone type 3, TZ3) was identified in more than half of these patients. Immunohistochemical markers p16 and Ki-67 demonstrated high sensitivity (95.5%) and negative predictive value (93.3%) for detecting CIN2+ lesions in hrHPV-positive women with low-grade cytology (NILM, ASC-US, and LSIL). Smoking status was significantly associated with CIN2+ lesions in this patient group (p < 0.001). Conclusions: Deferring further evaluation of hrHPV-positive women solely based on negative cytology may be unsafe, particularly in older women, smokers, and those positive for HPV16/18. The strong association between p16/Ki-67 positivity and CIN2+ lesions suggests that dual-stain testing directly from cytological samples could significantly improve triage strategies and reduce the need for invasive procedures.
Open AccessClinical Significance of High-Risk HPV Positivity with Negative Cytology: Can Further Evaluation Be Safely Delayed?
Background and Objectives: Primary HPV screening has high sensitivity in detecting premalignant and malignant cervical lesions. However, due to its relatively low specificity, this screening approach requires triage tests. Owing to its high specificity, cytology is most commonly employed in the triage of HPV-positive results. Nevertheless, the question remains as to how reliable cytology is in triaging these cases, given its relatively low sensitivity. This study evaluates the clinical significance of high-risk HPV (hrHPV) positivity in women with negative or low-grade cytological findings and assesses whether further evaluation can be safely deferred using HPV genotyping, colposcopy, and p16/Ki-67 biomarkers. Materials and Methods: A prospective hospital-based observational study was conducted on 125 women with a positive hrHPV cervical test. All participants underwent conventional cytology, extended HPV genotyping, colposcopy, and histopathological evaluation via biopsy or loop excision. Immunohistochemical analysis of p16 and Ki-67 expressions was performed on histopathological tissue samples. Particular attention was focused on women with negative for intraepithelial lesion or malignancy (NILM) and low-grade cytological findings. Associations between cytology, HPV genotype distribution, colposcopic findings, histopathology, smoking status, and biomarker expression were analyzed. Results: Among HPV-positive patients with NILM cytology, CIN2+ lesions were histopathologically confirmed in 28.0% of cases. More than half (51.4%) of all CIN2+ lesions detected in HPV-positive women were identified in patients with low-grade or negative cytology. HPV16/18 positivity was highly prevalent among women with CIN2+ lesions and low-grade cytological findings (78.4%). Unsatisfactory colposcopy with a non-visible squamocolumnar junction (transformation zone type 3, TZ3) was identified in more than half of these patients. Immunohistochemical markers p16 and Ki-67 demonstrated high sensitivity (95.5%) and negative predictive value (93.3%) for detecting CIN2+ lesions in hrHPV-positive women with low-grade cytology (NILM, ASC-US, and LSIL). Smoking status was significantly associated with CIN2+ lesions in this patient group (p < 0.001). Conclusions: Deferring further evaluation of hrHPV-positive women solely based on negative cytology may be unsafe, particularly in older women, smokers, and those positive for HPV16/18. The strong association between p16/Ki-67 positivity and CIN2+ lesions suggests that dual-stain testing directly from cytological samples could significantly improve triage strategies and reduce the need for invasive procedures.
- Open Access
- 15 July 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (7) , 750
Chemotherapy-Induced Brain Damage: Mechanisms and Insights from Rodent Models
Background/Objectives: Chemotherapy-induced cognitive impairment, colloquially known as chemobrain, affects a substantial proportion of cancer patients. Preclinical rodent models help clarify underlying drug-specific neurotoxic effects, as well as histological, biochemical, molecular, and behavioral mechanisms. Methods: We conducted a narrative review of animal studies examining cognitive dysfunction following treatment with commonly used chemotherapeutic agents, including doxorubicin, cisplatin, cyclophosphamide, methotrexate, 5-fluorouracil, paclitaxel, and docetaxel. The review focused on behavioral and cognitive outcomes, and experimental parameters such as rodent models and dosing regimens. Results: Across studies, chemotherapeutic exposure has had a consistent negative effect on short-term and working memory, learning and other cognitive domains, with impairments being often mild and detectable even at doses not causing apparent systemic toxicity. Histological analyses revealed reduced neurogenesis, dendritic and myelin alterations, and glial activation, mainly in the hippocampus and prefrontal cortex. Biochemical and molecular changes included oxidative stress, pro-apoptotic signaling, inflammatory cytokine dysregulation, decreased neurotrophic support, and altered neurotransmitter dynamics. Age and sex influenced susceptibility, with juvenile or aged animals and females—particularly older females modeling breast cancer patients—showing greater deficits. Cumulative or repeated dosing exacerbated neurotoxicity, while single administrations produced milder, sometimes transient, impairments. Conclusions: Preclinical models provide compelling evidence that chemotherapeutic agents impair cognitive function via convergent mechanisms involving inflammation, oxidative stress, and synaptic dysregulation. These findings highlight the importance of considering age, sex, and treatment schedule in designing neuroprotective strategies and underscore the translational relevance of rodent models in understanding chemobrain.
- 15 July 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (7) , 750
Open AccessChemotherapy-Induced Brain Damage: Mechanisms and Insights from Rodent Models
Background/Objectives: Chemotherapy-induced cognitive impairment, colloquially known as chemobrain, affects a substantial proportion of cancer patients. Preclinical rodent models help clarify underlying drug-specific neurotoxic effects, as well as histological, biochemical, molecular, and behavioral mechanisms. Methods: We conducted a narrative review of animal studies examining cognitive dysfunction following treatment with commonly used chemotherapeutic agents, including doxorubicin, cisplatin, cyclophosphamide, methotrexate, 5-fluorouracil, paclitaxel, and docetaxel. The review focused on behavioral and cognitive outcomes, and experimental parameters such as rodent models and dosing regimens. Results: Across studies, chemotherapeutic exposure has had a consistent negative effect on short-term and working memory, learning and other cognitive domains, with impairments being often mild and detectable even at doses not causing apparent systemic toxicity. Histological analyses revealed reduced neurogenesis, dendritic and myelin alterations, and glial activation, mainly in the hippocampus and prefrontal cortex. Biochemical and molecular changes included oxidative stress, pro-apoptotic signaling, inflammatory cytokine dysregulation, decreased neurotrophic support, and altered neurotransmitter dynamics. Age and sex influenced susceptibility, with juvenile or aged animals and females—particularly older females modeling breast cancer patients—showing greater deficits. Cumulative or repeated dosing exacerbated neurotoxicity, while single administrations produced milder, sometimes transient, impairments. Conclusions: Preclinical models provide compelling evidence that chemotherapeutic agents impair cognitive function via convergent mechanisms involving inflammation, oxidative stress, and synaptic dysregulation. These findings highlight the importance of considering age, sex, and treatment schedule in designing neuroprotective strategies and underscore the translational relevance of rodent models in understanding chemobrain.
- Open Access
- 4 July 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (13) , 2099
Diagnostic Significance of Ki-67, p53, and Mucin Glycoprotein Expression in Colorectal Serrated Lesions: Further Immunohistochemical Studies
Background/Objectives: Colorectal serrated lesions are highly heterogeneous at the micromorphological level. Their morphology can range from seemingly harmless, as in the case of hyperplastic polyps with little to no neoplastic potential, to lesions that can undergo malignant transformation within a short period of time. The serrated morphology of these lesions is primarily a consequence of morphological changes resulting from the enlargement and budding of the adenoma, as well as the migration of its epithelium at the crypt level. This creates elevations that resemble saw teeth. In this study, the serrated morphology was highlighted immunohistochemically using the MUC2 marker. Results: MUC5AC immunohistochemical expression exhibited greater variability in positivity and intensity compared to MUC2 expression. Pancryptic MUC5AC positivity was present in 75% of TSA cases and in 75% of malignantly transformed serrated lesions. This correlates with advanced histologic lesions and dysplasia development within the serrated pathway of carcinogenesis. MUC5AC is a useful marker for detecting polyps undergoing malignant transformation but not for distinguishing between sessile serrated lesions and hyperplastic polyps. Analysis of Ki-67 proliferative activity in serrated lesions in this study showed that a shift in the proliferative zone along the entire crypt was statistically significant only in TSA (p < 0.01). p53 expression increases from low-grade to high-grade dysplasia and malignant transformation of serrated lesions. This study confirmed that p53 expression in the upper half of the crypt was present in 11% of sessile serrated lesions without dysplasia and in 18% with dysplasia. In malignantly transformed serrated lesions, pancryptic positivity was present in 25% of cases. Conclusions: A marker panel consisting of mucin glycoproteins, Ki-67, and p53 could be useful in assessing the risk level of malignant transformation in serrated lesions.
- 4 July 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (13) , 2099
Open AccessDiagnostic Significance of Ki-67, p53, and Mucin Glycoprotein Expression in Colorectal Serrated Lesions: Further Immunohistochemical Studies
Background/Objectives: Colorectal serrated lesions are highly heterogeneous at the micromorphological level. Their morphology can range from seemingly harmless, as in the case of hyperplastic polyps with little to no neoplastic potential, to lesions that can undergo malignant transformation within a short period of time. The serrated morphology of these lesions is primarily a consequence of morphological changes resulting from the enlargement and budding of the adenoma, as well as the migration of its epithelium at the crypt level. This creates elevations that resemble saw teeth. In this study, the serrated morphology was highlighted immunohistochemically using the MUC2 marker. Results: MUC5AC immunohistochemical expression exhibited greater variability in positivity and intensity compared to MUC2 expression. Pancryptic MUC5AC positivity was present in 75% of TSA cases and in 75% of malignantly transformed serrated lesions. This correlates with advanced histologic lesions and dysplasia development within the serrated pathway of carcinogenesis. MUC5AC is a useful marker for detecting polyps undergoing malignant transformation but not for distinguishing between sessile serrated lesions and hyperplastic polyps. Analysis of Ki-67 proliferative activity in serrated lesions in this study showed that a shift in the proliferative zone along the entire crypt was statistically significant only in TSA (p < 0.01). p53 expression increases from low-grade to high-grade dysplasia and malignant transformation of serrated lesions. This study confirmed that p53 expression in the upper half of the crypt was present in 11% of sessile serrated lesions without dysplasia and in 18% with dysplasia. In malignantly transformed serrated lesions, pancryptic positivity was present in 25% of cases. Conclusions: A marker panel consisting of mucin glycoproteins, Ki-67, and p53 could be useful in assessing the risk level of malignant transformation in serrated lesions.
- Open Access
Diffuse Symptomatic Familial Gastric Polyposis Requiring Total Gastrectomy: A Complex Case Report
Background and Clinical Significance: Familial gastric polyposis is a rare condition associated with an increased risk of malignant transformation, particularly in patients with a strong family history of gastrointestinal malignancies. Case Presentation: We report the case of a 46-year-old female presenting with severe epigastric pain, persistent vomiting, and significant weight loss. Endoscopic and histopathological evaluation confirmed diffuse fundic gland polyposis with intestinal metaplasia involving the entire gastric mucosa. Given the extensive disease, pronounced symptoms, and significant familial cancer burden, the patient underwent total gastrectomy with Roux-en-Y esophagojejunostomy. The postoperative course was uneventful, with satisfactory recovery and favorable functional outcomes during follow-up. This case highlights the clinical challenges associated with diffuse symptomatic familial gastric polyposis and underscores the importance of timely surgical intervention in high-risk patients. Conclusions: Due to clinical complexity of such presentations, detailed case descriptions remain important for guiding clinical practice.
Open AccessDiffuse Symptomatic Familial Gastric Polyposis Requiring Total Gastrectomy: A Complex Case Report
Background and Clinical Significance: Familial gastric polyposis is a rare condition associated with an increased risk of malignant transformation, particularly in patients with a strong family history of gastrointestinal malignancies. Case Presentation: We report the case of a 46-year-old female presenting with severe epigastric pain, persistent vomiting, and significant weight loss. Endoscopic and histopathological evaluation confirmed diffuse fundic gland polyposis with intestinal metaplasia involving the entire gastric mucosa. Given the extensive disease, pronounced symptoms, and significant familial cancer burden, the patient underwent total gastrectomy with Roux-en-Y esophagojejunostomy. The postoperative course was uneventful, with satisfactory recovery and favorable functional outcomes during follow-up. This case highlights the clinical challenges associated with diffuse symptomatic familial gastric polyposis and underscores the importance of timely surgical intervention in high-risk patients. Conclusions: Due to clinical complexity of such presentations, detailed case descriptions remain important for guiding clinical practice.
- Open Access
Pathological and Diagnostic Assessment of Duodenal Wound Healing: A Comparative Experimental Study of Jejunal Serosal vs. ePTFE Patch Repair
Background and Objectives: The treatment of duodenal injuries remains one of the most challenging issues in clinical surgery due to their high morbidity and mortality rates. The primary objective of this study was to evaluate the histopathology and other diagnostic outcomes of wound repair following surgical reconstruction of large experimental duodenal defects using synthetic (ePTFE, expanded polytetrafluoroethylene) or organic (JSP, jejunal serosal patch) materials. Materials and Methods: A total of 20 European rabbits were randomly divided into two equal groups (n = 10 each). A grade III defect covering over 50% of the duodenum’s circumference was created in the second part of the duodenum of the rabbits. The anesthesia, duodenal injury, postoperative care, and animal sacrifice protocols were identical for all experimental rabbits. The effectiveness of JSP and ePTFE patch repair techniques was investigated based on clinical, macroscopic, and microscopic assessments at two and four weeks postoperatively. Results: Survival rates were comparable between groups (p > 0.05). Remarkable mucosal regeneration was evident in all experimental animals by two weeks, showing complete coverage of the jejunal serosal and ePTFE patches by re-epithelialized mucosa with functional villus formation. While partial development of the underlying muscular and serosal layers was observed in both groups at four weeks, the JSP group achieved a significantly higher median histological score (19 vs. 14; p = 0.003). Conversely, the ePTFE group exhibited a major safety concern: a highly significant increase (p ≤ 0.001) in Grade 4 dense, inseparable adhesions throughout the abdominal cavity, which were entirely absent in the JSP group. Conclusions: Both JSP and ePTFE are viable for duodenal reconstruction, but the autologous JSP is superior in tissue healing and safety. Severe adhesions associated with ePTFE constitute a significant clinical concern, limiting its use to a second-line alternative. Consequently, JSP is the preferred option, while ePTFE requires further long-term safety validation.
Open AccessPathological and Diagnostic Assessment of Duodenal Wound Healing: A Comparative Experimental Study of Jejunal Serosal vs. ePTFE Patch Repair
Background and Objectives: The treatment of duodenal injuries remains one of the most challenging issues in clinical surgery due to their high morbidity and mortality rates. The primary objective of this study was to evaluate the histopathology and other diagnostic outcomes of wound repair following surgical reconstruction of large experimental duodenal defects using synthetic (ePTFE, expanded polytetrafluoroethylene) or organic (JSP, jejunal serosal patch) materials. Materials and Methods: A total of 20 European rabbits were randomly divided into two equal groups (n = 10 each). A grade III defect covering over 50% of the duodenum’s circumference was created in the second part of the duodenum of the rabbits. The anesthesia, duodenal injury, postoperative care, and animal sacrifice protocols were identical for all experimental rabbits. The effectiveness of JSP and ePTFE patch repair techniques was investigated based on clinical, macroscopic, and microscopic assessments at two and four weeks postoperatively. Results: Survival rates were comparable between groups (p > 0.05). Remarkable mucosal regeneration was evident in all experimental animals by two weeks, showing complete coverage of the jejunal serosal and ePTFE patches by re-epithelialized mucosa with functional villus formation. While partial development of the underlying muscular and serosal layers was observed in both groups at four weeks, the JSP group achieved a significantly higher median histological score (19 vs. 14; p = 0.003). Conversely, the ePTFE group exhibited a major safety concern: a highly significant increase (p ≤ 0.001) in Grade 4 dense, inseparable adhesions throughout the abdominal cavity, which were entirely absent in the JSP group. Conclusions: Both JSP and ePTFE are viable for duodenal reconstruction, but the autologous JSP is superior in tissue healing and safety. Severe adhesions associated with ePTFE constitute a significant clinical concern, limiting its use to a second-line alternative. Consequently, JSP is the preferred option, while ePTFE requires further long-term safety validation.
- Open Access
- 21 March 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (6) , 660
Differences in Histological Subtypes of Invasive Lobular Breast Carcinoma According to Immunohistochemical Molecular Classification
The technical complexity of gene expression profiling in routine practice has necessitated the use of surrogate molecular classification of breast cancer, based on immunohistochemical analyses. Background and objectives: The aim of this study was to compare the differences between histological and molecular subtypes of invasive lobular carcinoma (ILC) of the breast, in order to be able to predict the behavior and prognosis of the disease, as well as to effectively determine therapy. Material and Methods: This study included 263 cases of breast ILC diagnosed over a seven-year period. The diagnosis of invasive lobular carcinoma is based on the characteristic growth pattern and phenotype of cancer cells with the respective subtypes: classic, alveolar, solid, tubulolobular, pleomorphic and mixed lobular type. The examined cases were divided into five groups according to molecular classification based on the expression of ER, PR, HER2 and Ki67 immunohistochemical markers. Results: It was found that the pleomorphic subtype occurred statistically significantly less often as the luminal A subtype compared to others (p = 0.00027), and the HER2-enriched subtype occurred statistically significantly more often in the pT4 stage (p = 0.024). Conclusions: The results of this study significantly singled out the luminal A subtype, and among them classic ILC, as the subtype with the most favorable expression ratio of the investigated predictive/prognostic immunohistochemical markers.
- 21 March 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (6) , 660
Open AccessDifferences in Histological Subtypes of Invasive Lobular Breast Carcinoma According to Immunohistochemical Molecular Classification
The technical complexity of gene expression profiling in routine practice has necessitated the use of surrogate molecular classification of breast cancer, based on immunohistochemical analyses. Background and objectives: The aim of this study was to compare the differences between histological and molecular subtypes of invasive lobular carcinoma (ILC) of the breast, in order to be able to predict the behavior and prognosis of the disease, as well as to effectively determine therapy. Material and Methods: This study included 263 cases of breast ILC diagnosed over a seven-year period. The diagnosis of invasive lobular carcinoma is based on the characteristic growth pattern and phenotype of cancer cells with the respective subtypes: classic, alveolar, solid, tubulolobular, pleomorphic and mixed lobular type. The examined cases were divided into five groups according to molecular classification based on the expression of ER, PR, HER2 and Ki67 immunohistochemical markers. Results: It was found that the pleomorphic subtype occurred statistically significantly less often as the luminal A subtype compared to others (p = 0.00027), and the HER2-enriched subtype occurred statistically significantly more often in the pT4 stage (p = 0.024). Conclusions: The results of this study significantly singled out the luminal A subtype, and among them classic ILC, as the subtype with the most favorable expression ratio of the investigated predictive/prognostic immunohistochemical markers.
- Open Access
- 1 December 2023
- Published by University of Nis Faculty of Medicine in AFMN Biomedicine
- Vol. 41 (2) , 252-262
Adrenal incidentalomas: A seven-year follow-up single-center experience
Adrenal incidentalomas (AIs) are defined as tumours revealed during imaging procedures of abdomen or abdominal laparotomy, performed in patients without previous suspicion for adrenal disease. This study was conducted to evaluate morphological and functional features of AIs seven years after the initial diagnosis. Thirty-eight AI patients were monitored for seven years, with CT scans used for morphological follow-up. Hormonal activity assessments included basal cortisol levels, adrenocorticotropic hormone, overnight Dexamethasone suppression test, plasma or urinary metanephrines, vanillymandelic acid, electrolytes, hematocrit, acid-base status, oral glucose tolerance test, and chromogranin A. Functional activity was confirmed in six patients, with mild autonomous cortisol secretion (MACS) detected in two patients. Nine patients underwent adrenalectomy. Histopathological examination revealed hormonal activity in six cases, adrenocortical carcinoma was found in one patient, while secondary deposits from bronchial carcinoma were detected in one patient. Among the remaining 29 patients observed for the first year, tumor size remained stable. After seven years, two patients experienced tumor enlargement ≥ 1 cm, along with the development of MACS on endocrine evaluation. Adrenalectomy was recommended for one patient due to tumor size exceeding 4 cm. The initial adrenal incidentaloma (AI) evaluation must include comprehensive diagnostic procedures for surgical consideration. Subsequent follow-up should include CT imaging after 12 months to monitor the tumor growth. Although mild autonomous cortisol secretion does not tend to progress to overt Cushing's syndrome, it can develop in patients initially considered to have hormonally inactive tumor. Our findings suggest that even small adrenal masses (< 4 cm) can enlarge over seven years, potentially evolving into MACS. Therefore, regular long-term monitoring every 5 - 7 years is recommended.
- 1 December 2023
- Published by University of Nis Faculty of Medicine in AFMN Biomedicine
- Vol. 41 (2) , 252-262
Open AccessAdrenal incidentalomas: A seven-year follow-up single-center experience
Adrenal incidentalomas (AIs) are defined as tumours revealed during imaging procedures of abdomen or abdominal laparotomy, performed in patients without previous suspicion for adrenal disease. This study was conducted to evaluate morphological and functional features of AIs seven years after the initial diagnosis. Thirty-eight AI patients were monitored for seven years, with CT scans used for morphological follow-up. Hormonal activity assessments included basal cortisol levels, adrenocorticotropic hormone, overnight Dexamethasone suppression test, plasma or urinary metanephrines, vanillymandelic acid, electrolytes, hematocrit, acid-base status, oral glucose tolerance test, and chromogranin A. Functional activity was confirmed in six patients, with mild autonomous cortisol secretion (MACS) detected in two patients. Nine patients underwent adrenalectomy. Histopathological examination revealed hormonal activity in six cases, adrenocortical carcinoma was found in one patient, while secondary deposits from bronchial carcinoma were detected in one patient. Among the remaining 29 patients observed for the first year, tumor size remained stable. After seven years, two patients experienced tumor enlargement ≥ 1 cm, along with the development of MACS on endocrine evaluation. Adrenalectomy was recommended for one patient due to tumor size exceeding 4 cm. The initial adrenal incidentaloma (AI) evaluation must include comprehensive diagnostic procedures for surgical consideration. Subsequent follow-up should include CT imaging after 12 months to monitor the tumor growth. Although mild autonomous cortisol secretion does not tend to progress to overt Cushing's syndrome, it can develop in patients initially considered to have hormonally inactive tumor. Our findings suggest that even small adrenal masses (< 4 cm) can enlarge over seven years, potentially evolving into MACS. Therefore, regular long-term monitoring every 5 - 7 years is recommended.
- Open Access
The Importance of Immunohistochemical Heterogeneous Expression of MMR Protein in Patients with Colorectal Cancer in Stage II and III of the Disease
Background and objectives: In patients with colorectal cancer (CRC), heterogeneous expression of Mismatch repair (MMR) proteins can manifest itself in several different forms and is not such a rare phenomenon. Therefore, it is very important to recognize the nuclear expression of MMR proteins of different MMR status in order to avoid false positive or false negative results. The aim of this study was to determine the frequency and distribution of heterogeneous expression of MMR proteins in patients with stages II and III of the disease as well as its association with clinical, demographic and pathological characteristics of CRC in relation to proficient and deficient expression of MMR proteins. Material and Methods: The study included 104 cases of colorectal cancer obtained from surgical colectomy material in stages II and III of the disease. Results: From a total of 104 patients with colorectal cancer, immunohistochemical analysis of the expression of all four MMR proteins showed that heterogeneous expression of MMR proteins (as well as deficient immunoreactivity of tumor cells) was present in 12 cases, while proficient expression of MMR proteins was detected in 80 tumors. Conclusions: Our study showed that the only independent predictors of the loss of MMR protein expression were younger patient age and right-sided anatomical location of the tumor. The study also established the existence of heterogeneous expression of MMR proteins in a non-negligible percentage of CRCs (11.5%), where heterogeneous nuclear expression of MMR proteins was described in several different forms.
Open AccessThe Importance of Immunohistochemical Heterogeneous Expression of MMR Protein in Patients with Colorectal Cancer in Stage II and III of the Disease
Background and objectives: In patients with colorectal cancer (CRC), heterogeneous expression of Mismatch repair (MMR) proteins can manifest itself in several different forms and is not such a rare phenomenon. Therefore, it is very important to recognize the nuclear expression of MMR proteins of different MMR status in order to avoid false positive or false negative results. The aim of this study was to determine the frequency and distribution of heterogeneous expression of MMR proteins in patients with stages II and III of the disease as well as its association with clinical, demographic and pathological characteristics of CRC in relation to proficient and deficient expression of MMR proteins. Material and Methods: The study included 104 cases of colorectal cancer obtained from surgical colectomy material in stages II and III of the disease. Results: From a total of 104 patients with colorectal cancer, immunohistochemical analysis of the expression of all four MMR proteins showed that heterogeneous expression of MMR proteins (as well as deficient immunoreactivity of tumor cells) was present in 12 cases, while proficient expression of MMR proteins was detected in 80 tumors. Conclusions: Our study showed that the only independent predictors of the loss of MMR protein expression were younger patient age and right-sided anatomical location of the tumor. The study also established the existence of heterogeneous expression of MMR proteins in a non-negligible percentage of CRCs (11.5%), where heterogeneous nuclear expression of MMR proteins was described in several different forms.
- Open Access
- 26 February 2023
- Published by MDPI AG in Gastroenterology Insights
- Vol. 14 (1) , 110-120
Significance of Micromorphological Characteristics and Expression of Intermediate Filament Proteins CK7 and CK20 in the Differential Diagnosis of Serrated Lesions of the Colorectum
Serrated lesions in the colorectum include all epithelial neoplastic lesions, which show a sawtooth-like morphology in the epithelial crypts. Classification systems nosologically divide colon serrated polyps into three different categories, primarily emphasizing their micromorphological growth pattern and cytodifferentiation: (1) hyperplastic polyps, (2) sessile serrated adenomas/polyps and (3) traditional serrated adenomas. Overall, 109 patients with serrated lesions of the colon, who underwent endoscopic or surgical polypectomy/tumorectomy during one or multiple endoscopic or surgical interventions, over a four-year period, were analyzed. The average age of patients was 62.8 ± 11.6 years. The frequency of serrated lesions of the colon in male patients was 2.4 times higher than in females (70.6% vs. 29.4%). All sessile serrated lesions without dysplasia were positive for CK7 and statistically significant compared to other serrated lesions, if this positivity was present in the complete crypt (p = 0.005). CK20 positivity, which is limited to the upper half of the crypt, is a special feature of hyperplastic polyps compared to other serrated lesions, which is statistically significant (p = 0.0078). Whereas, CK20 positivity of complete crypts is a statistically significant feature of traditional serrated adenomas (p < 0.01). Differences in the expression pattern of cytokeratin 7 and 20 in different serrated lesions may indicate different pathways of colorectal carcinogenesis, and be diagnostically and prognostically useful.
- 26 February 2023
- Published by MDPI AG in Gastroenterology Insights
- Vol. 14 (1) , 110-120
Open AccessSignificance of Micromorphological Characteristics and Expression of Intermediate Filament Proteins CK7 and CK20 in the Differential Diagnosis of Serrated Lesions of the Colorectum
Serrated lesions in the colorectum include all epithelial neoplastic lesions, which show a sawtooth-like morphology in the epithelial crypts. Classification systems nosologically divide colon serrated polyps into three different categories, primarily emphasizing their micromorphological growth pattern and cytodifferentiation: (1) hyperplastic polyps, (2) sessile serrated adenomas/polyps and (3) traditional serrated adenomas. Overall, 109 patients with serrated lesions of the colon, who underwent endoscopic or surgical polypectomy/tumorectomy during one or multiple endoscopic or surgical interventions, over a four-year period, were analyzed. The average age of patients was 62.8 ± 11.6 years. The frequency of serrated lesions of the colon in male patients was 2.4 times higher than in females (70.6% vs. 29.4%). All sessile serrated lesions without dysplasia were positive for CK7 and statistically significant compared to other serrated lesions, if this positivity was present in the complete crypt (p = 0.005). CK20 positivity, which is limited to the upper half of the crypt, is a special feature of hyperplastic polyps compared to other serrated lesions, which is statistically significant (p = 0.0078). Whereas, CK20 positivity of complete crypts is a statistically significant feature of traditional serrated adenomas (p < 0.01). Differences in the expression pattern of cytokeratin 7 and 20 in different serrated lesions may indicate different pathways of colorectal carcinogenesis, and be diagnostically and prognostically useful.